| |
| |
|
| Insider
Information: |
Scangos George A |
| Relationship: |
Director |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
937,662 |
|
|
Indirect Shares
|
3,762,360 |
|
|
| Direct
Value |
$29,796,828 |
|
|
|
Indirect Value
|
$4,756,396 |
|
|
| Total
Shares |
4,700,022 |
|
|
| Total
Value |
$34,553,224 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Exelixis Inc |
EXEL |
Director |
2020-05-18 |
714,717 |
2020-05-18 |
23,595 |
Premium* |
|
|
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2008-08-26 |
33,188 |
2004-03-31 |
0 |
Premium* |
|
|
Biogen Idec Inc |
BIIB |
Chief Executive Office... |
2016-07-21 |
54,779 |
2016-07-21 |
10,756 |
Premium* |
|
|
Agilent Technologies Inc |
A |
Director |
2024-03-15 |
21,989 |
2024-03-15 |
14,450 |
Premium* |
|
|
Vir Biotechnology, Inc. |
VIR |
Director |
2024-02-26 |
112,989 |
2024-02-26 |
3,713,559 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
376 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 13 of 16
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2015-03-02 |
4 |
AS |
$410.67 |
$338,803 |
D/D |
(825) |
45,713 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-05-01 |
4 |
AS |
$215.39 |
$344,193 |
D/D |
(1,598) |
50,509 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-11-01 |
4 |
AS |
$138.64 |
$344,640 |
D/D |
(2,472) |
51,670 |
0 |
- |
|
| A |
Agilent Technologies Inc |
Director |
• • – |
2021-03-18 |
4 |
A |
$121.59 |
$344,838 |
D/D |
2,836 |
16,544 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-02-24 |
4 |
AS |
$22.74 |
$352,682 |
D/D |
(15,119) |
168,489 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2012-07-17 |
4 |
AS |
$146.04 |
$361,011 |
D/D |
(2,472) |
65,105 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2016-02-23 |
4 |
D |
$258.99 |
$361,291 |
D/D |
(1,395) |
61,417 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-11-01 |
4 |
AS |
$14.14 |
$366,400 |
D/D |
(25,000) |
1,511,981 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-10-01 |
4 |
AS |
$330.97 |
$373,003 |
D/D |
(1,127) |
19,113 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-06-03 |
4 |
AS |
$234.16 |
$374,188 |
D/D |
(1,598) |
48,911 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-08-01 |
4 |
AS |
$332.93 |
$375,545 |
D/D |
(1,128) |
21,368 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2014-09-02 |
4 |
AS |
$345.47 |
$389,690 |
D/D |
(1,128) |
20,240 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-24 |
4 |
AS |
$26.24 |
$393,600 |
D/D |
(15,000) |
738,031 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-02-12 |
4 |
AS |
$20.02 |
$420,420 |
D/D |
(21,000) |
1,013,031 |
0 |
% |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-09-24 |
4 |
S |
$16.85 |
$421,250 |
D/D |
(25,000) |
1,561,981 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2018-10-01 |
4 |
AS |
$17.86 |
$446,500 |
D/D |
(25,000) |
1,536,981 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-12-27 |
4 |
AS |
$18.25 |
$456,250 |
D/D |
(25,000) |
1,090,531 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-04-15 |
4 |
AS |
$18.31 |
$457,750 |
D/D |
(25,000) |
913,031 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-09-03 |
4 |
AS |
$213.30 |
$480,042 |
D/D |
(2,239) |
43,522 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-08-01 |
4 |
AS |
$218.82 |
$489,938 |
D/D |
(2,239) |
45,761 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-06-03 |
4 |
AS |
$19.61 |
$490,250 |
D/D |
(25,000) |
1,223,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2019-05-01 |
4 |
AS |
$19.75 |
$493,750 |
D/D |
(25,000) |
1,248,031 |
0 |
- |
|
| EXEL |
Exelixis Inc |
Director |
– • – |
2020-01-22 |
4 |
AS |
$19.75 |
$493,750 |
D/D |
(25,000) |
1,038,031 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
Chief Executive Officer |
• • – |
2013-07-16 |
4 |
AS |
$223.94 |
$501,402 |
D/D |
(2,239) |
48,000 |
0 |
- |
|
| VIR |
Vir Biotechnology, Inc. |
President and CEO |
• • – |
2023-02-21 |
4 |
AS |
$28.02 |
$505,318 |
D/D |
(17,856) |
196,239 |
0 |
- |
|
376 Records found
|
|
Page 13 of 16 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
